Total Number of Shares and Voting Rights
On March 31, 2020
| Total number of outstanding shares |
Theoretical voting rights | Exercisable voting rights (minus treasury shares) |
| 65,798,801 | 65,798,801 | 65,419,241 |
Last updated on
Last updated on
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.